Disagreement between urinary and circulating levels of KIM-1 were also observed in a case-control analysis from the ACCORD trial (the Action to Control Cardiovascular Disease Trial), conducted in patients with type 2 diabetes. The gene discussed is HAVCR1; the disease is cardiovascular disorder.